Semaglutide SM10 10mg*10vials

Retatroptide RT100 (10mg x 10 vials) is the pinnacle of the Retatroptide GLP-1/GIP/GCGR triple receptor agonist series, representing an industry benchmark for peptide drugs in global metabolic research. RT100 integrates the iterative technological advantages of the entire RT10/RT15/RT20/RT30/RT40/RT50/RT60 product line, employing industry-exclusive ultra-high-density saturated molecular reconstruction technology and comprehensive, ultimate-activity formulation iteration. It achieves 100% target saturation binding, ultimate metabolic regulation strength, and ultra-stable experimental performance with zero fluctuations, surpassing all previous RT series products in terms of bioactivity, therapeutic range, and experimental tolerability. As the highest-dose, most potent, and top-tier custom-designed research product in the Retatroptide commercial product line, RT100 is specifically tailored for exploring ultra-limit metabolic boundaries, studying ultra-high-dose therapeutic mechanisms, validating ultra-long-term large-scale animal models, and conducting cutting-edge, highly challenging metabolic pharmacology research. It is a top-quality core ingredient used by leading pharmaceutical R&D institutions and specialized high-end laboratories worldwide.

Product Functions and Research Value

RT100 possesses fully saturated three-pathway synergistic metabolic regulation capabilities, enabling comprehensive, in-depth, and extreme intervention in various refractory and complex systemic metabolic disorders. Its fully saturated, highly active GLP-1 and GIP dual pathways achieve ultimate optimization of insulin sensitivity, completely reversing severe refractory insulin resistance, maintaining long-term stable blood glucose levels without fluctuations, and providing ultra-long-acting, potent appetite suppression and sustained satiety. It provides ultra-precise, authoritative, and reliable experimental support for in-depth exploration of the complex pathological mechanisms of diabetes, refractory glucose and lipid metabolism disorders, and the boundary theory of extreme insulin resistance. The fully amplified GCGR pathway can elevate resting energy metabolism to the absolute physiological limits of model organisms, thoroughly breaking down deep visceral stubborn fat and long-term accumulated adipose tissue, fundamentally improving refractory severe dyslipidemia, and completing comprehensive and deep browning remodeling of white adipose tissue. It is perfectly suited for cutting-edge research scenarios, such as metabolic remodeling in extremely refractory severe obesity, repair of irreversible damage to higher metabolic organs, validation of ultra-limit dose-response boundaries, and exploration of multidimensional and complex metabolic disorder mechanisms. RT100 can generate extremely significant differential experimental phenotypes, providing highly reproducible and stable data throughout its lifecycle, as well as extremely high model study validity, providing strong support for top-tier academic achievements and ultra-high-standard preclinical drug research. Core Product Advantages

1. RT100 Supreme Ultimate Fully Saturated Activity: The top-of-the-line final version of the Retatropeptide series, employing exclusive molecular full reconstruction and saturation optimization technology. Its target-binding activity and comprehensive metabolic regulation efficacy reach the industry peak, far exceeding RT60 and all lower-generation products, providing the most extreme and significant experimental phenotypic differences for ultra-high-standard cutting-edge scientific research. 2. 100mg Supreme Concentration: The highest-end customized flagship specification in the RT series, with concentrations of: 10 times the standard 10mg, 5 times 20mg, 3.3 times 30mg, 2.5 times 40mg, 2 times 50mg, and 1.67 times 60mg. It is perfectly suited for ultra-long-term large animal models, ultra-extreme high-dose gradient limit control experiments, and large-scale, multi-parallel, ultra-large-scale repeated tests, completely eliminating experimental errors and data fluctuations caused by frequent dilution and solution changes, significantly improving experimental accuracy and efficiency. 3. Absolutely Stable and Zero Degradation Throughout the Experimental Cycle: Utilizing industry-leading, latest fully stable molecular reconstruction and modification technology, it exhibits superior resistance to decay and degradation in complex in vivo and in vitro experimental environments. Maintaining 100% biological activity throughout the entire ultra-long experimental cycle without any attenuation, it achieves absolute zero-difference batch consistency and ultra-high data repeatability. 4. Pharmaceutical grade, top-tier ultra-high purity: Utilizing imported aseptic vacuum freeze-drying technology, the original biological activity of peptide molecules is fully preserved. Each batch of products undergoes rigorous, fully parallel testing.